CSIMarket
 

Hims and Hers Health Inc   (HIMS)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Hims And Hers Health Inc 's Working Capital Per Sales

HIMS's Working Capital and Revenue growth



HIMS Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change 4.7 % 0.62 % -3.87 % -7.74 % -11.55 %
Y / Y Revenue Change 48.15 % 56.25 % 82.42 % 88.3 % 97.41 %
Working Capital Per Revenue 0.2 0.21 0.24 0.28 0.33
Total Ranking # 662 # 1511 # 1506 # 931 # 929
Seq. Working Capital Change 5.31 % -0.25 % -0.67 % 0.35 % 1.21 %
Seq. Revenue Change 9.46 % 9.24 % 8.59 % 14.09 % 15.44 %





Comment on HIMS's Working Capital Per Revenue in the fourth quarter 2023
Hims And Hers Health Inc 's Working Capital Per Revenue in the Q4 2023 sequentially fell to 0.2 a new company low.

Within Healthcare sector 11 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Hims And Hers Health Inc Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 662, from total ranking in the third quarter 2023 at 1511.
Working Capital Per Revenue Ranking
Within: No.
Industry # 1
Sector # 12
S&P 500 # 662


Working Capital Per Revenue Statistics
High Average Low
0.96
0.43
0.2
(Dec 31 2021)   (Dec 31 2023)



Financial Statements
Hims And Hers Health Inc 's Working Capital $ 177 Millions Visit HIMS's Balance sheet
Hims And Hers Health Inc 's Revenues $ 248 Millions Visit HIMS's Income Statement
Where are HIMS's Sales coming from? Visit HIMS's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Lantheus Holdings Inc   0.53 
Star Equity Holdings Inc   0.53 
Biogen Inc   0.53 
Zoetis Inc   0.52 
Neurocrine Biosciences Inc   0.51 
Elanco Animal Health Inc  0.50 
Nephros Inc   0.50 
Electrocore Inc   0.49 
Jazz Pharmaceuticals Plc  0.49 
Protalix Biotherapeutics inc   0.49 
Pro dex Inc   0.48 
Avanos Medical Inc   0.46 
West Pharmaceutical Services Inc   0.46 
Integra Lifesciences Holdings Corp  0.46 
Eton Pharmaceuticals Inc   0.45 
Xeris Biopharma Holdings Inc   0.45 
Ironwood Pharmaceuticals inc   0.44 
Atricure Inc   0.44 
Haemonetics Corporation  0.43 
Edwards Lifesciences Corporation  0.43 
Phibro Animal Health Corporation  0.42 
Merit Medical Systems Inc  0.41 
Assertio Holdings inc   0.40 
Bio techne Corp  0.40 
Zynex inc   0.39 
Medtronic Plc  0.39 
Pfizer Inc  0.39 
Catalyst Pharmaceuticals Inc   0.38 
Palatin Technologies Inc   0.38 
Teladoc Health Inc   0.37 
Date modified: 2024-02-27T10:38:16+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com